News

Get more out of your business.

Reach it with Microsoft Dynamics 365 Business Central.

May 11, 2017 Katie Quinn

Biosimilars Forum Statement Regarding Newly Released EMA Information Guide on Biosimilars For Healthcare Professionals

May 10, 2017 Katie Quinn

Biosimilars Forum Statement Regarding Confirmation of Dr. Scott Gottlieb as Commissioner of the Food and Drug Administration

May 3, 2017 Katie Quinn

Biosimilars Forum Submits Comments in Response to FDA’s Draft Guidance for Industry on Interchangeability for Biosimilar Products

March 14, 2017 Katie Quinn

Biosimilars Forum Congratulates Seema Verma on Confirmation as Next Administrator of the Centers for Medicare and Medicaid Services

March 13, 2017 Katie Quinn

Biosimilars Forum Statement Regarding Nomination of Dr. Scott Gottlieb as Next Commissioner of the Food and Drug Administration

March 2, 2017 Katie Quinn

Past President of Biosimilars Forum Testifies before Congress Regarding BsUFA

January 17, 2017 Katie Quinn

Biosimilars Forum Statement Regarding FDA’s Draft Guidance for Industry on Interchangeability for Biosimilar Products

January 12, 2017 Katie Quinn

Biosimilars Forum Statement Regarding FDA’s Final Guidance on Nonproprietary Naming of Biosimilar Products

January 11, 2017 Katie Quinn

Biosimilars Forum Statement Regarding the CMS’ Treatment of Biosimilars Under the Medicaid Drug Rebate Program

November 1, 2016 Katie Quinn

Awareness of Biosimilars Among U.S. Specialty Physicians is High but New Survey Identifies Five Major Knowledge Gaps